Joseph J. Grudzinski, Ph.D.

2010 University of Wisconsin, Madison, Madison, WI 
Oncology, Medical Biophysics, Radiation Physics
"Joseph Grudzinski"
Mean distance: (not calculated yet)


Sign in to add mentor
Robert Jeraj grad student 2010 UW Madison
 (A whole-body pharmacokinetic model for the early assessment of targeted radionuclide therapy agents.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Besemer AE, Yang YM, Grudzinski JJ, et al. (2018) Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosimetry Platform. Cancer Biotherapy & Radiopharmaceuticals
Besemer AE, Titz B, Grudzinski JJ, et al. (2017) Impact of PET and MRI threshold-based tumor volume segmentation on patient-specific targeted radionuclide therapy dosimetry using CLR1404. Physics in Medicine and Biology. 62: 6008-6025
Zhang RR, Schroeder AB, Grudzinski JJ, et al. (2017) Beyond the margins: real-time detection of cancer using targeted fluorophores. Nature Reviews. Clinical Oncology
Grudzinski JJ, Titz B, Kozak K, et al. (2014) A phase 1 study of 131I-CLR1404 in patients with relapsed or refractory advanced solid tumors: dosimetry, biodistribution, pharmacokinetics, and safety. Plos One. 9: e111652
Grudzinski JJ, Floberg JM, Mudd SR, et al. (2012) Application of a whole-body pharmacokinetic model for targeted radionuclide therapy to NM404 and FLT. Physics in Medicine and Biology. 57: 1641-57
Grudzinski JJ, Tomé W, Weichert JP, et al. (2010) The biological effectiveness of targeted radionuclide therapy based on a whole-body pharmacokinetic model. Physics in Medicine and Biology. 55: 5723-34
Grudzinski JJ, Burnette RR, Weichert JP, et al. (2010) Dosimetric effectiveness of targeted radionuclide therapy based on a pharmacokinetic landscape. Cancer Biotherapy & Radiopharmaceuticals. 25: 417-26
Grudzinski JJ, Yoriyaz H, DeLuca PM, et al. (2010) Patient specific treatment planning for systemically administered radiopharmaceuticals using PET/CT and Monte Carlo simulation Applied Radiation and Isotopes. 68: 59-65
See more...